Join
today
Boliven PRO is more than just patent search
- Build and save lists using the powerful Lists feature
- Analyze and download your search results
- Share patent search results with your clients
Patents »
US7682373: Vascular wound closure device and method
Filing Information
| Inventor(s) |
Yong Hua Zhu ·
Wolff M. Kirsch ·
|
| Assignee(s) |
Loma Linda University Medical Center ·
View assignee updates
|
| Attorney/Agent(s) |
Knobbe, Martens, Olson & Bear, LLP ·
|
| Primary Examiner |
Anhtuan T Nguyen ·
|
| Assistant Examiner |
Kathleen Sonnett ·
|
| Application Number | US10463754 |
| Filing date | 06/16/2003 |
| Issue date | 03/23/2010 |
| Prior Publication Data | |
| Predicted expiration date | 07/03/2023 |
| Patent term adjustment | 701 |
| U.S. Classifications |
606/213 ·
604/59 ·
604/15 ·
|
| International Classifications |
A61B1703 ·
|
| Kind Code | B2 |
| Related U.S. Application Data | RELATED APPLICATIONS This application claims priority to U.S. Application Ser. No. 60/389,239, which was filed Jun. 14, 2002, the entirety of which is hereby incorporated by reference. This application also claims priority as a continuation-in-part of U.S. application Ser. No. 09/921,158, now U.S. Pat. No. 6,890,342, which was filed on Aug. 1, 2001, and which claims priority to U.S. Application Ser. No. 60/222,525, filed on Aug. 2, 2000, the entirety of both of which is hereby incorporated by reference. |
Patent Family
35 Claims, 32 Drawings
Abstract
A method and apparatus for closing a vascular wound includes a guidewire and/or other surgical implement extending from the wound. A hemostatic material is advanced over the surgical implement and into contact with an area of the blood vessel surrounding the wound. The surgical implement is removed. Blood soaks the hemostatic material, and blood clotting is facilitated by the hemostatic agent within the material. A sealing layer of adhesive can be applied to the hemostatic material, confining the blood flow to the material. Thus, the vascular puncture wound is sealed by natural blood clot formation.
- 1. An assembly for closing a vascular wound comprising:
a hemostatic material adapted to facilitate blood clotting sufficient to close the vascular wound;
a delivery tube defining a chamber configured to accommodate the hemostatic material therewithin, the delivery tube having a proximal end and a distal end, the hemostatic material being carried within the chamber;
an apparatus configured to position the distal end of the delivery tube at or near a vascular wound; and
a pusher member having a distal portion configured to fit at least partially through the proximal end of the delivery tube without deforming the delivery tube, the pusher member and delivery tube releasably connected to one another with the distal portion of the pusher member fit at least partially into the proximal end of the delivery tube and proximal of the hemostatic material within the chamber, a portion of the pusher member having a diameter larger than an inner diameter of at least a portion of the delivery tube;
wherein the pusher member and delivery tube are configured so that as the pusher member is moved distally relative to the delivery tube while the hemostatic material remains within the chamber, the pusher member engages the delivery tube proximal of at least a portion of the hemostatic material and through that engagement deforms the delivery tube so as to create at least one opening for the hemostatic material to exit the chamber.
- 21. A method for closing a vascular wound, comprising:
providing an assembly comprising a delivery tube and a pusher member, the delivery tube defining a chamber having a hemostatic material disposed therewithin, the pusher member having a distal portion configured to fit at least partially through a proximal end of the delivery tube, an engagement portion of the pusher member having a diameter larger than an inner diameter of at least a portion of the delivery tube, the chamber being substantially closed so that the hemostatic material remains enclosed within the chamber and the pusher member engagement portion disposed generally proximal of the hemostatic material;
positioning the distal end of the delivery tube at or near a vascular wound; and
moving the pusher member distally relative to the delivery tube so that the engagement portion of the pusher member engages the delivery tube at a location proximal to at least a portion of the hemostatic material and deforms at least a portion of the delivery tube so as to create at least one opening;
wherein after the at least one opening is formed by the pusher member deforming the delivery tube, the hemostatic material begins to be dispatched from the chamber, and the hemostatic material is dispatched from the chamber through the at least one opening.
- 30. An assembly for closing a vascular wound comprising:
a hemostatic material;
a delivery tube having a proximal end and a distal end, an inner wall of the delivery tube defining a chamber that accommodates the hemostatic material therewithin, a first portion of the chamber having a first diameter, a second portion of the chamber being proximal of the first portion and having a second diameter greater than the first diameter, and a third portion of the chamber being proximal of the second portion and having a third diameter greater than the second diameter;
a catheter extending through the delivery tube, the chamber being defined between the catheter and the inner wall, the distal end of the delivery tube engaging the catheter so that the chamber is closed at its distal end;
an apparatus configured to position the distal end of the delivery tube at or near a vascular wound;
a pusher member having an engagement portion configured to fit within the third portion of the chamber, the engagement portion of the pusher member having a diameter greater than the first and second chamber portion diameters, but less than or equal to the third chamber portion diameter; and
the hemostatic material being within the chamber between the first portion and the third portion, the chamber enclosing the hemostatic material therewithin, the engagement portion of the pusher member being disposed generally proximal of the hemostatic material;
wherein the pusher member and chamber are configured so that when the pusher member is moved distally relative to the delivery tube, the hemostatic material remains enclosed within the chamber and generally distal of the pusher member engagement portion until the pusher member engagement portion engages the inner wall in the second chamber portion and deforms the delivery tube so that at least one opening is created in the chamber, and the pusher member dispatches the hemostatic material through the at least one opening created when the pusher member deforms the delivery tube.
References Cited
U.S. Patent Documents
| Document Number | Assignees | Inventors | Issue/Pub Date |
| US1064307 |
|
Fleming |
Jun 1913 |
| US3518993 |
AMERICAN HOSPITAL SUPPLY CORP |
Blake |
Jul 1970 |
| US3653388 |
BATTELLE DEVELOPMENT CORP |
Tenckhoff |
Apr 1972 |
| US3893454 |
STILLE WERNER AB |
Hagelin |
Jul 1975 |
| US4116469* |
|
Harriman et al. |
Sep 1978 |
| US4166469* |
LITTLEFORD PHILIP O |
Littleford |
Sep 1979 |
| US4317445 |
Baxter Travenol Laboratories, Inc. |
Robinson |
Mar 1982 |
| US4412832* |
Baxter Travenol Laboratories, Inc. |
Kling et al. |
Nov 1983 |
| US4451256* |
Intermedicat GmbH |
Weikl et al. |
May 1984 |
| US4530698 |
The United States of America as represented by the Department of Health and Human Services |
Goldstein et al. |
Jul 1985 |
| US4532134* |
MALETTE WILLIAM GRAHAM |
Malette et al. |
Jul 1985 |
| US4585437 |
SIMMS MARK D |
Simms |
Apr 1986 |
| US4622970 |
The Johns Hopkins University |
Wozniak |
Nov 1986 |
| US4738658 |
Aries Medical Incorporated |
Magro et al. |
Apr 1988 |
| US4772266 |
Catheter Technology Corp. |
Groshong |
Sep 1988 |
| US4821719 |
FOGARTY THOMAS J |
Fogarty |
Apr 1989 |
| US4865593 |
Sherwood Medical Company |
Ogawa et al. |
Sep 1989 |
| US4889112 |
Waltap Ltd. |
Schachner et al. |
Dec 1989 |
| US4890612 |
Kensey Nash Corporation |
Kensey |
Jan 1990 |
| US4900303 |
LEMELSON JEROME H |
Lemelson |
Feb 1990 |
| US4921479 |
GRAYZEL JOSEPH |
Grayzel |
May 1990 |
| US4961729 |
VAILLANCOURT VINCENT L |
Vaillancourt |
Oct 1990 |
| US4984564 |
YUEN FRANK |
Yuen |
Jan 1991 |
| US5002557 |
HASSON HARRITH M |
Hasson |
Mar 1991 |
| US5057083 |
C. R. Bard, Inc. |
Gellman |
Oct 1991 |
| US5152279 |
WILK PETER J |
Wilk |
Oct 1992 |
| US5176128 |
ANDRESE CRAIG A |
Andrese |
Jan 1993 |
| US5176129 |
Tekdyne, Inc. |
Smith |
Jan 1993 |
| US5183464 |
Interventional Thermodynamics, Inc. |
Dubrul et al. |
Feb 1993 |
| US5192301* |
Nippon Zeon Co., Ltd. |
Kamiya et al. |
Mar 1993 |
| US5222974 |
Kensey Nash Corporation |
Kensey et al. |
Jun 1993 |
| US5242387 |
Brigham & Women's Hospital |
Loughlin |
Sep 1993 |
| US5250033 |
Interventional Thermodynamics, Inc. |
Evans et al. |
Oct 1993 |
| US5257979 |
|
Jagpal |
Nov 1993 |
| US5259835 |
Tri-Point Medical L.P. |
Clark et al. |
Nov 1993 |
| US5282827 |
Kensey Nash Corporation |
Kensey et al. |
Feb 1994 |
| US5290310* |
Howmedica, Inc. |
Makower et al. |
Mar 1994 |
| US5292332 |
LEE BENJAMIN I |
Lee |
Mar 1994 |
| US5300065 |
Proclosure Inc. |
Anderson |
Apr 1994 |
| US5306254 |
Kensey Nash Corporation |
Nash et al. |
Apr 1994 |
| US5320639 |
Meadox Medicals, Inc. |
Rudnick |
Jun 1994 |
| US5324306 |
Howmedica, Inc. |
Makower et al. |
Jun 1994 |
| US5391183 |
Datascope Investment Corp |
Janzen et al. |
Feb 1995 |
| US5423814 |
Loma Linda University Medical Center |
Zhu et al. |
Jun 1995 |
| US5431639 |
Boston Scientific Corporation |
Shaw |
Jul 1995 |
| US5437631* |
Datascope Investment Corp. |
Janzen |
Aug 1995 |
| US5443484* |
Loma Linda University Medical Center |
Kirsch et al. |
Aug 1995 |
| US5626601 |
Gary Gershony |
Gershony et al. |
May 1997 |
| US5643318 |
Boston Scientific Corporation |
Tsukernik et al. |
Jul 1997 |
| US5665106 |
Hemodynamics, Inc. |
Hammerslag |
Sep 1997 |
| US5665107 |
Hemodynamics, Inc. |
Hammerslag |
Sep 1997 |
| US5674231 |
United States Surgical Corporation |
Green et al. |
Oct 1997 |
| US5676689* |
Kensey Nash Corporation |
Kensey et al. |
Oct 1997 |
| US5725551 |
|
Myers et al. |
Mar 1998 |
| US5728132 |
Tricardia, L.L.C. |
Van Tassel et al. |
Mar 1998 |
| US5759194 |
Hemodynamics, Inc. |
Hammerslag |
Jun 1998 |
| US5810810 |
Scimed Life Systems, Inc. |
Tay et al. |
Sep 1998 |
| US5836970 |
The Kendall Company |
Pandit |
Nov 1998 |
| US5843124* |
Hemodynamics, Inc. |
Hammerslag |
Dec 1998 |
| US5876387 |
Biovac Medizintechnik GmbH |
Killian et al. |
Mar 1999 |
| US5910155* |
United States Surgical Corporation |
Ratcliff et al. |
Jun 1999 |
| US5928266 |
X-Site, L.L.C. |
Kontos |
Jul 1999 |
| US5944730 |
Cardio Medical Solutions, Inc. |
Nobles et al. |
Aug 1999 |
| US5971956 |
BioSurgical Corporation |
Epstein |
Oct 1999 |
| US6004341* |
Loma Linda University Medical Center |
Zhu et al. |
Dec 1999 |
| US6007563 |
Kensey Nash Corporation |
Nash et al. |
Dec 1999 |
| US6033413 |
Endocare, Inc. |
Mikus et al. |
Mar 2000 |
| US6048358 |
|
Barak |
Apr 2000 |
| US6056768 |
|
Cates et al. |
May 2000 |
| US6060461 |
|
Drake |
May 2000 |
| US6155265 |
Hemodynamics, Inc. |
Hammerslag |
Dec 2000 |
| US5589269 |
Minnesota Mining and Manufacturing Company |
Zhu et al. |
Feb 2001 |
| US6197042 |
Medical Technology Group, Inc. |
Ginn et al. |
Mar 2001 |
| US6198016 |
3M Innovative Properties Company |
Lucast et al. |
Mar 2001 |
| US6277140 |
Integrated Vascular Systems, Inc. |
Ginn et al. |
Aug 2001 |
| US6287322 |
Loma Linda University Medical Center |
Zhu et al. |
Sep 2001 |
| US6287323 |
Hemodynamics, Inc. |
Hammerslag |
Sep 2001 |
| US6315753 |
Sub-Q, Inc. |
Cragg et al. |
Nov 2001 |
| US6325789 |
Datascope Investment Corporation |
Janzen et al. |
Dec 2001 |
| US6346093 |
SciMed Life Systems, Inc. |
Allman et al. |
Feb 2002 |
| US6371974 |
Sub Q, Inc. |
Brenneman et al. |
Apr 2002 |
| US6391048 |
Integrated Vascular Systems, Inc. |
Ginn et al. |
May 2002 |
| US6425901* |
Loma Linda University Medical Center |
Zhu et al. |
Jul 2002 |
| US6461364 |
Integrated Vascular Systems, Inc. |
Ginn et al. |
Oct 2002 |
| US6508828 |
Radi Medical Systems AB |
Akerfeldt et al. |
Jan 2003 |
| US6524326 |
Loma Linda University Medical Center |
Zhu et al. |
Feb 2003 |
| US6623510 |
Integrated Vascular Systems, Inc. |
Carley et al. |
Sep 2003 |
| US6626918 |
Medical Technology Group |
Ginn et al. |
Sep 2003 |
| US6632238 |
Integrated Vascular Systems, Inc. |
Ginn et al. |
Oct 2003 |
| US6649162 |
Baxter Aktiengesellschaft |
Biering et al. |
Nov 2003 |
| US6890342 |
Loma Linda University |
Zhu et al. |
May 2005 |
| US6964675* |
Loma Linda University Medical Center |
Zhu et al. |
Nov 2005 |
| US7201725 |
Sub-Q, Inc. |
Cragg et al. |
Apr 2007 |
| US20010004710 |
|
Felt et al. |
Jun 2001 |
| US20010018598 |
|
Cruise et al. |
Aug 2001 |
| US20020002386 |
Integrated Vascular Systems, Inc. |
Ginn et al. |
Jan 2002 |
| US20020022822 |
|
Cragg et al. |
Feb 2002 |
| US20020072768 |
|
Ginn |
Jun 2002 |
| US20020077656 |
Integrated Vascular Systems, Inc. |
Ginn et al. |
Jun 2002 |
| US20020077657 |
Integrated Vascular Systems, Inc. |
Ginn et al. |
Jun 2002 |
| US20020147479 |
Integrated Vascular Systems, Inc. |
Aldrich |
Oct 2002 |
| US20030023267 |
Core Medical, Inc. |
Ginn |
Jan 2003 |
| US20030044380 |
|
Zhu et al. |
Mar 2003 |
| US20030045893 |
Integrated Vascular Systems, Inc. |
Ginn |
Mar 2003 |
| US20030050590 |
|
Kirsch |
Mar 2003 |
| US20030050665 |
Integrated Vascular Systems, Inc. |
Ginn |
Mar 2003 |
| US20030078598 |
Integrated Vascular Systems, Inc. |
Ginn et al. |
Apr 2003 |
| US20030109820 |
|
Gross et al. |
Jun 2003 |
| US20030158577 |
Integrated Vascular Systems, Inc. |
Ginn et al. |
Aug 2003 |
| US20030158578 |
Integrated Vascular Systems, Inc. |
Pantages et al. |
Aug 2003 |
| US20030167050 |
|
Prosl et al. |
Sep 2003 |
| US20050095275 |
|
Zhu et al. |
May 2005 |
| US20050107826* |
|
Zhu et al. |
May 2005 |
| US20050118238 |
|
Zhu et al. |
Jun 2005 |
| US20050123588 |
|
Zhu et al. |
Jun 2005 |
| US20050142172 |
|
Kirsch et al. |
Jun 2005 |
| US20050209637* |
ZHU YONG H |
Zhu et al. |
Sep 2005 |
| US20050240137 |
ZHU YONG H |
Zhu et al. |
Oct 2005 |
| US20060064124* |
|
Zhu et al. |
Mar 2006 |
| US20070123816 |
ZHU YONG H |
Zhu et al. |
May 2007 |
Foreign Patent Documents
* cited by examiner
Other Publications
| “Medafor, Inc., Adds Two Management Team Members”, Press Release, Jun. 7, 2001 http://www.medafor.com/news0601.html.* |
| Angio-Seal, Hemostasis Puncture Closure Device Brochure, Sherwood Medical Co., Jun. 11, 1997. |
| Gershony, Gary, M.D., A Novel Femoral Access Site Closure Device: Duet, Early European Clinical Trials, Los Angeles Cardiology Associates, Seminar, Coronary Interventions, Oct. 16-18, 1997. |
| “Microporous Polysaccharide Hemispheres Provides Effective Topical Hemostasis in a Human Modified Bleeding Time Incision Model” by Medafore, Sep. 2002. |
* cited by examiner
Referenced By
The current document is not referenced by other documents.
Patent Family
The current document is not in a family.
Boliven’s Predicted Expiration Date includes in its calculation the number of days of patent term adjustment a U.S. patent is entitled. The Predicted Expiration Date does not, currently, include in its calculation the payment of maintenance fees, the filing of any disclaimer(s), and/or patent term extension, but Boliven is working to include this information in the near future.